Follow India’s COVID-19 updates by city and state here.


Google has announced that an employee at its office in Bangalore, Karnataka, India tested positive for the novel coronavirus.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to an internal email, the 26-year-old employee contracted the virus during overseas travel. The patient passed the screening test at the airport but was screened again later after feeling uncomfortable at work.

Google spokesperson was quoted by local media as saying: “We can confirm that an employee from our Bangalore office has been diagnosed with COVID-19. They were in one of our Bangalore offices for a few hours before developing any symptoms.”

The technology giant has asked all remaining employees in the office to work from home on 13 March as a precautionary measure.

People who were in close contact with the infected employee have been asked to self-quarantine.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Over recent days, Google asked all its employees across several regions, including Europe and North America, to work from home in an effort to control the spread of coronavirus.

India reported nearly 80 COVID-19 cases so far, including the Google employee. The country also confirmed its first coronavirus-related death on 12 March in a 76-year-old man in Karnataka.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact